Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Chi-Cheng Lin0

Chin-Yao Yang0

Yi-Hsin Lin0

Fang-Yu Liu0

Li Qiao0

K. C. Sung0

Date of Patent

August 20, 2024

0

Patent Application Number

180965980

Date Filed

January 13, 2023

0

Patent Citations

US Patent 10238602 Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies

0

US Patent 10548888 C-Met modulator pharmaceutical compositions

0

US Patent 10736886 Methods of using c-Met modulators

0

US Patent 10940149 Kinase inhibitor salts and compositions thereof

0

US Patent 11007195 Kinase inhibitor salts, and compositions thereof

0

US Patent 11052088 Kinase inhibitor salts, and compositions thereof

0

US Patent 11065240 Drug combinations to treat multiple myeloma

0

US Patent 11091439 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

Patent abstract

The present invention relates to cabozantinib lauryl sulfate salt and methods of use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12064430 Kinase inhibitor salts and compositions thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.